Clindamycin dosing for mrsa

risk or suspicion of CA-MRSA or failure to improve on clindamycin, consider a change to mg/kg/dose q8h (see dosing section), if hardware present or MRSA

dosing) if MRSA screen positive or MRSA infection in last 3 months. Clindamycin 450mg QDS IV for 5 days. Oral switch: 300mg QDS. Send MRSA

Clindamycin phosphate IV or clindamycin hydrochloride orally in a dose clindamycin-resistant MRSA-strains excludes the use of clindamycin for infections due

dose of gentamicin with clindamycin was found to be safe and effective in MRSA infection included MRSA colonization, open abdom- inal aortic

If MRSA clindamycin susceptible: Clindamycin. 10mg/kg/dose PO q8h (max dose: 450mg). If low suspicion for MRSA or. MRSA PCR negative or MSSA.

Clindamycin phosphate IV or clindamycin hydrochloride orally in a dose of mg clindamycin-resistant MRSA-strains excludes the use of clindamycin

Our findings support age-based dosing. Keywords. MRSA; population pharmacokinetics; clindamycin; pediatrics. Clindamycin is a lincosamide

4) The treatment of choice for MRSA is intravenous vancomycin, not clindamycin in any form. If your child had a MRSA infection, clindamycin

clindamycin-susceptible MRSA strains and in children when clindamycin resistance to MRSA is 10%. Finally, The Pediatric Infectious